tiprankstipranks
Lantern Pharma Advances AI-Driven Cancer Therapies
PremiumCompany AnnouncementsLantern Pharma Advances AI-Driven Cancer Therapies
2M ago
Lantern Pharma reports Q3 EPS (42c), one estimate (56c)
Premium
The Fly
Lantern Pharma reports Q3 EPS (42c), one estimate (56c)
2M ago
Lantern Pharma granted fast track designation for LP-184
Premium
The Fly
Lantern Pharma granted fast track designation for LP-184
3M ago
Lantern progresses toward diagnostic for LP-184 for oncology clinical trials use
PremiumThe FlyLantern progresses toward diagnostic for LP-184 for oncology clinical trials use
7M ago
Lantern receives certificate of patent from Japan Patent Office for LP-284
Premium
The Fly
Lantern receives certificate of patent from Japan Patent Office for LP-284
7M ago
Lantern Pharma files $150M mixed securities shelf
Premium
The Fly
Lantern Pharma files $150M mixed securities shelf
8M ago
Lantern Pharma Announces Fiscal Year and Q4 Results Webinar
PremiumCompany AnnouncementsLantern Pharma Announces Fiscal Year and Q4 Results Webinar
10M ago
Lantern Pharma reports Q4 EPS (39c), two estimates (40c)
Premium
The Fly
Lantern Pharma reports Q4 EPS (39c), two estimates (40c)
10M ago
Lantern Pharma doses first two patients in LP-284 trial
Premium
The Fly
Lantern Pharma doses first two patients in LP-284 trial
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100